Skin Cancer Diagnostic Market Revenue 2024 to 2034
Skin Cancer Diagnostic Market Revenue 2024 to 2034
Skin Cancer Diagnostic Market (By Type of Cancer: Melanoma, Basal Cell Carcinoma, Others; By Diagnostic Test/Technique: Visual Examination & Dermoscopy, Biopsy, Imaging Tests, Molecular & Genetic Tests, Others; By Diagnostic Tool/Device: Dermatoscopes, Imaging Systems, Biopsy Instruments, Molecular Diagnostic Kits, AI & Tele-dermatology Platforms; By End User: Hospitals & Cancer Centers, Dermatology Clinics, Diagnostic Laboratories, Ambulatory Surgical Centers, Home-based & Tele-dermatology Platforms;) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2034.
Customisation Request
Revenue,
USD 8.54 Bn
Forecast Year,
USD 8.97 Bn
CAGR, 2025 -
5.04%
Report Coverage
Worldwide
Published By
Yogesh Kulkarni
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global skin cancer diagnostic market was valued at USD 8.54 billion in 2024 and is projected to grow from USD 8.97 billion in 2025 to USD 13.96 billion by 2034, expanding at a CAGR of 5.04%. Growth is driven by rising incidence of skin cancer, advancements in diagnostic technologies, and increasing awareness for early detection and screening.
Skin Cancer Diagnostic Market Size Analysis
Skin Cancer Diagnostic Market Size By Type of Cancer 2024 to 2034 (USD Billion)
| Type of Cancer | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Melanoma | 2.56 | 2.71 | 2.86 | 3.03 | 3.20 | 3.39 | 3.58 | 3.78 | 4.00 | 4.23 | 4.47 |
| Basal Cell Carcinoma | 3.42 | 3.58 | 3.75 | 3.93 | 4.12 | 4.31 | 4.52 | 4.74 | 4.96 | 5.20 | 5.45 |
| Squamous Cell Carcinoma | 2.14 | 2.23 | 2.34 | 2.44 | 2.56 | 2.68 | 2.80 | 2.93 | 3.06 | 3.20 | 3.35 |
| Others | 0.43 | 0.45 | 0.47 | 0.49 | 0.52 | 0.55 | 0.57 | 0.60 | 0.63 | 0.66 | 0.70 |
Skin Cancer Diagnostic Market Size By Diagnostic Test-Technique 2024 to 2034 (USD Billion)
| Diagnostic Test-Technique | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Visual Examination & Dermoscopy | 2.39 | 2.50 | 2.62 | 2.74 | 2.87 | 3.00 | 3.14 | 3.29 | 3.44 | 3.60 | 3.77 |
| Biopsy | 2.99 | 3.11 | 3.24 | 3.38 | 3.51 | 3.66 | 3.81 | 3.96 | 4.13 | 4.29 | 4.47 |
| Imaging Tests | 1.54 | 1.62 | 1.71 | 1.81 | 1.91 | 2.02 | 2.13 | 2.25 | 2.38 | 2.51 | 2.65 |
| Molecular & Genetic Tests | 1.02 | 1.12 | 1.22 | 1.34 | 1.46 | 1.58 | 1.72 | 1.87 | 2.02 | 2.19 | 2.37 |
| Others | 0.60 | 0.61 | 0.62 | 0.63 | 0.64 | 0.66 | 0.67 | 0.67 | 0.68 | 0.69 | 0.70 |
Skin Cancer Diagnostic Market Size By Diagnostic Tool-Device 2024 to 2034 (USD Billion)
| Diagnostic Tool-Device | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dermatoscopes | 1.88 | 1.96 | 2.04 | 2.12 | 2.20 | 2.29 | 2.39 | 2.48 | 2.58 | 2.69 | 2.79 |
| Imaging Systems | 2.14 | 2.24 | 2.36 | 2.47 | 2.60 | 2.73 | 2.87 | 3.01 | 3.16 | 3.32 | 3.49 |
| Biopsy Instruments | 2.39 | 2.49 | 2.60 | 2.71 | 2.83 | 2.95 | 3.07 | 3.20 | 3.34 | 3.48 | 3.63 |
| Molecular Diagnostic Kits | 0.85 | 0.91 | 0.98 | 1.05 | 1.12 | 1.20 | 1.28 | 1.37 | 1.47 | 1.57 | 1.68 |
| AI & Tele-dermatology Platforms | 1.28 | 1.36 | 1.45 | 1.54 | 1.64 | 1.75 | 1.86 | 1.98 | 2.10 | 2.23 | 2.37 |
Skin Cancer Diagnostic Market Size By End User 2024 to 2034 (USD Billion)
| End User | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals & Cancer Centers | 2.99 | 3.12 | 3.26 | 3.40 | 3.56 | 3.71 | 3.88 | 4.05 | 4.23 | 4.41 | 4.61 |
| Dermatology Clinics | 2.56 | 2.69 | 2.83 | 2.97 | 3.12 | 3.28 | 3.44 | 3.61 | 3.80 | 3.99 | 4.19 |
| Diagnostic Laboratories | 1.71 | 1.79 | 1.88 | 1.98 | 2.08 | 2.18 | 2.29 | 2.41 | 2.53 | 2.66 | 2.79 |
| Ambulatory Surgical Centers | 0.85 | 0.89 | 0.92 | 0.96 | 1.00 | 1.04 | 1.08 | 1.12 | 1.16 | 1.21 | 1.26 |
| Home-based & Tele-dermatology Platforms | 0.43 | 0.48 | 0.53 | 0.58 | 0.64 | 0.71 | 0.78 | 0.86 | 0.94 | 1.02 | 1.12 |
Skin Cancer Diagnostic Market Size By Region 2024 to 2034 (USD Billion)
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 3.25 | 3.39 | 3.54 | 3.70 | 3.87 | 4.04 | 4.22 | 4.41 | 4.61 | 4.81 | 5.03 |
| Asia Pacific | 2.39 | 2.54 | 2.69 | 2.86 | 3.04 | 3.22 | 3.42 | 3.63 | 3.85 | 4.08 | 4.33 |
| Europe | 2.31 | 2.41 | 2.53 | 2.64 | 2.77 | 2.89 | 3.03 | 3.17 | 3.32 | 3.47 | 3.63 |
| LAMEA | 0.60 | 0.63 | 0.66 | 0.69 | 0.73 | 0.76 | 0.80 | 0.84 | 0.89 | 0.93 | 0.98 |
Skin Cancer Diagnostic Market Size to Hit USD 13.96 Billion by 2034
The global skin cancer diagnostic market was valued at USD 8.54 billion in 2024 and is projected to grow from USD 8.97 billion in 2025 to USD 13.96 billion by 2034, expanding at a CAGR of 5.04%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
